FDA Inspection 1177788 — Gipsco Investment Corp
The FDA completed an inspection of Gipsco Investment Corp on July 22, 2022 in Beachwood, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 22, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Beachwood, OH (United States)